Neoss
www.neoss.comNeoss® was founded in 2000 by Fredrik Engman and Professor Neil Meredith, with the objective of “Advancing the Science of Dental Implant Treatment”. Convinced that existing implant systems were too complex, their idea was to create a much simpler and more rationalized solution. Through persistent effort and close collaborations they created a high-quality, optimized implant system. With a limited number of components, the Neoss Implant System has unique design features and a host of excellent advantages for everyone. This ingenuity lies in the patented implant design optimizing stability in all bone qualities and conditions and eliminating the need for separate one- or two-stage designs. The minimal platform concept utilizes only two implant platforms to support diameters in the range 3.25–6.5mm. This also greatly simplifies surgical and prosthetic instrumentation aiding communication within the team and increasing efficiently. The benefits are clear: reducing patient treatment time, optimizing inventory control and superior outcomes for patients. Neoss' head office is located in the UK, with subsidiaries in Australia, Austria, Italy, Germany, Middle East and Africa, New Zealand, Sweden and the United States. We are represented by professional partners in China, Croatia, Japan, Netherlands, Saudi Arabia, Spain, Switzerland, Thailand, Turkey, UAE and more.
Read moreNeoss® was founded in 2000 by Fredrik Engman and Professor Neil Meredith, with the objective of “Advancing the Science of Dental Implant Treatment”. Convinced that existing implant systems were too complex, their idea was to create a much simpler and more rationalized solution. Through persistent effort and close collaborations they created a high-quality, optimized implant system. With a limited number of components, the Neoss Implant System has unique design features and a host of excellent advantages for everyone. This ingenuity lies in the patented implant design optimizing stability in all bone qualities and conditions and eliminating the need for separate one- or two-stage designs. The minimal platform concept utilizes only two implant platforms to support diameters in the range 3.25–6.5mm. This also greatly simplifies surgical and prosthetic instrumentation aiding communication within the team and increasing efficiently. The benefits are clear: reducing patient treatment time, optimizing inventory control and superior outcomes for patients. Neoss' head office is located in the UK, with subsidiaries in Australia, Austria, Italy, Germany, Middle East and Africa, New Zealand, Sweden and the United States. We are represented by professional partners in China, Croatia, Japan, Netherlands, Saudi Arabia, Spain, Switzerland, Thailand, Turkey, UAE and more.
Read moreCountry
City (Headquarters)
Harrogate
Industry
Founded
2000
Estimated Revenue
$10,000,000 to $50,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
Member of the Executive Management Board , Vice President Global Marketing
Email ****** @****.comPhone (***) ****-****Vice President Corporate Development
Email ****** @****.comPhone (***) ****-****Managing Director
Email ****** @****.comPhone (***) ****-****Director Clinical Affairs
Email ****** @****.comPhone (***) ****-****
Technologies
(59)